Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
09/2001
09/19/2001EP1133512A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133510A2 Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133509A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133508A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133507A2 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133506A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP1133505A1 Carbohydrates and methods for their synthesis
09/19/2001EP1133303A2 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
09/19/2001EP0912162B1 Solid oral anticariogenic composition for cleaning the buccal cavity and teeth, and process for preparing this composition
09/19/2001EP0649417B1 Improved chemiluminescent 1,2-dioxetanes
09/19/2001CN1313860A 2-(purin-9-YL)-tetrahydrofuran-3,4-diol, derivatives
09/19/2001CN1313785A Liquid thickener for surfactant systems
09/18/2001US6291434 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
09/18/2001US6291433 Derivatives of α-D-Thioxyloside and their use against atheroma
09/18/2001US6290948 Using certain chemokines or biologically active fragments thereof alone or in conjunction with an anti-infective agent or hematopoietic maturing agent.
09/13/2001WO2001066554A2 Solid phase synthesis method and reagent
09/13/2001WO2001066100A2 Pharmaceutical composition
09/13/2001DE10010420A1 New ethylhexyl polyglucoside with a high degree of polymerization, useful as an emulsfier in industrial surface cleaner concentrates based on concentrated alkali
09/12/2001EP1132370A2 Process for producing n-substituted polyhydroxy nitrogen-containing heterocyles
09/12/2001EP1131330A1 Chemiluminescent substrates for neuraminidase, assays for detection of neuraminidase and kits therefor
09/12/2001EP1131311A1 2-acylamino-2-deoxy-glucono-1,5-lactones, method for obtaining same, compositions comprising them and uses
09/12/2001EP1131075A2 Use of phosphonoformic acid derivatives for treating infections
09/12/2001EP0831864B1 Processed ginseng having enhanced pharmacological effect
09/11/2001US6288277 Drugs, antiarthritic agants, antihistamines for treatment of asthma
09/11/2001US6288234 Fluorinated heterocyclic amido amine compounds as drugs
09/11/2001US6288041 Sialic acid derivatives
09/07/2001WO2001064605A2 Generation and screening of a dynamic combinatorial library
09/07/2001WO2001038337A3 Protecting groups useful in the synthesis of polysaccharides, natural products, and combinatorial libraries
09/07/2001WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
09/07/2001WO2000071571A3 Fap-activated anti-tumor compounds
09/06/2001US20010020089 Purine derivatives
09/06/2001US20010019837 Process for microbially oxidizing n-substituted glucamines
09/05/2001EP1130026A2 Alkylpolyglucosid with a high degree of oligomerization
09/05/2001EP1130017A2 Azole derivatives and their use as superoxide radical inhibitors
09/05/2001EP1130009A1 Generation and screening of a dynamic combinatorial library
09/05/2001EP1129208A1 Vancoresmycin, a process for its production and its use as a pharmaceutical
09/05/2001CN1070361C Composition for treatment and protection of keratinous made mainly of N-aliphatic acryl sphingol and vinylpyrrolidone polymer
09/04/2001US6284738 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
09/04/2001US6284737 Methods of treatment with anthracycline derivatives
08/2001
08/30/2001WO2001062769A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
08/30/2001WO2001014394A3 Derivatized reduced malto-oligosaccharides
08/30/2001US20010018425 New compounds for the treatment of cancer
08/30/2001EP1144424A3 Derivatized reduced malto-oligosaccharides
08/29/2001EP1127265A1 Method for non-invasive imaging oxygen distribution in multi-dimensions and apparatus therefor
08/29/2001EP1126856A1 Compounds and their therapeutic use with diabetic complications
08/28/2001US6281342 Pradimicin compounds
08/28/2001US6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancers
08/28/2001US6281197 Inhibiting the export of a leaderless protein such as fgf from a cell by contacting the cell with a cardiac glycoside
08/28/2001US6281196 Isolated from western pacific marine sponge agelas sp.
08/28/2001US6280777 Soya extract, process for its preparation and pharmaceutical composition
08/23/2001WO2001061353A1 Method of detecting subject to be analyzed
08/23/2001WO2001060835A1 Purine derivatives
08/23/2001WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
08/23/2001WO2001060324A1 Skin preparations for external use
08/23/2001WO2001007029A3 Substituted guanidines and the use thereof
08/23/2001CA2400857A1 Skin preparations for external use
08/23/2001CA2400619A1 Purine derivatives
08/22/2001EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use
08/22/2001EP1124980A2 Method for the production of quercetin and isoquercetin derivatives
08/22/2001EP1124836A1 Chromogenic substrates of sialidase and methods of making and using the same
08/22/2001EP1124815A1 Method for producing luteolin and luteolin derivatives
08/22/2001EP1124813A1 Microbial transformation product
08/22/2001EP1124528A1 Multivalent macrolide antibiotics
08/16/2001WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method
08/16/2001WO2001058932A1 Cytostatic agent glycoconjugate
08/16/2001EP1123310A1 Gene cluster involved in nogalamycin biosynthesis, and its use in production of hybrid antibiotics
08/16/2001EP1123263A1 Processing of contaminated fatty alcohol mixtures
08/16/2001EP1123096A1 Bioflavonoids as plasma high density lipoprotein level increasing agent
08/16/2001EP0837867B1 MODIFIED ALPHA-D-Glcp-(1-2)-ALPHA-D-Glcp-(1-3)-ALPHA-D-Glcp-ANALOGUES
08/16/2001EP0688330B1 New o-sulfated gangliosides and lyso-ganglioside derivatives
08/16/2001CA2398923A1 A group of anti-cancer compounds with specific structure and their production method
08/15/2001CN1308059A Colchicine derivative and is treatment use
08/14/2001US6274716 Combinatorial library of moenomycin analogs and methods of producing same
08/14/2001US6274086 Matrix comprising arrays of excitation light-transmitting optical fibers and phosphorescence-detecting/transmitting optical fibers whereby pulses of light are sequentially emitted and phosphorescence detected at a plurality of sites
08/10/2001WO2000047595A1 Ether type lipid a1-carboxylic acid analogues
08/10/2001CA2362246A1 Ether type lipid a1-carboxylic acid analogues
08/09/2001WO2001057054A1 Polyglyceryl glycosides, preparation method, composition containing same and use as surfactants
08/09/2001WO2001057053A1 Method for preparing functionalised beta-(1,3)-glucan derivatives
08/09/2001WO2001056959A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
08/09/2001DE10005275A1 Neuartige Glycokonjugate Novel glycoconjugates
08/09/2001CA2762121A1 The use of bicyclo [3.2.1]octan or kaurene for the treatment of non-insulin dependent diabetes mellitus, hypertension and metabolic syndrome
08/08/2001EP1122260A1 Crystallization of doxorubicin hydrochloride
08/08/2001CN1307473A Triterpene compositions and methods for use thereof
08/07/2001US6271425 Reacting an organic halide with oxygen molecules in the presence of an organotin compound and a reducing agent and optionally a free-radical inhibitor
08/07/2001US6271342 Sugar-modified cytostatics
08/07/2001CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment
08/02/2001WO2001055157A1 N-SUBSTITUTED DERIVATIVES OF 4-AMINO-4,6-DIDESOXY-α-D-GLUCOPYRANOSYL-(1→4)-α-D-GLUCOPYRANOSYL-(1→4)-D-GLUCOPYRANOSE AND 4-AMINO-4,6-DIDESOXY-α-D-GLUCOPYRANOSYL-(1→4)-α-D-GLUCOPYRANOSYL-(1→4)-β-D-GLUCOPYRANOSIDE AND PREPARATION METHOD
08/02/2001WO2001054702A1 Novel compounds
08/02/2001WO2001054691A1 Nitrate salts of antimicrobial agents
08/02/2001CA2398643A1 Novel compounds
08/02/2001CA2397754A1 Nitrate salts of antimicrobial agents
08/01/2001EP1120652A1 Enhancement of chemiluminescence in assays
08/01/2001EP1120423A1 Improved chemiluminescent 1,2-dioxetanes
08/01/2001EP1120422A1 Improved chemiluminescent 1,2-dioxetanes
08/01/2001EP1119577A2 Synthesis of oligosaccharides, reagents and methods related thereto
07/2001
07/31/2001US6268488 Active therapeutic agent attached to blocking moiety that is sensitive to catalytic action of molecules having retro-aldol and retro-michael catalytic activity; targeted antitumor, cytotoxic and antibiotic therapy
07/26/2001WO2001053292A1 Dendrimer precursor dyes for imaging
07/26/2001WO2001052746A1 Versatile hydrophilic dyes
07/25/2001EP1118617A1 Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation
07/25/2001EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use